The Competition Council warns that the acquisition of the Regina Maria health network by Mehiläinen Oy may affect competition in assisted human reproduction services.

The Competition Council announced that the acquisition of the Regina Maria health network by the Finnish company Mehiläinen Oy could negatively influence competition in the market for assisted human reproduction services, with the risk of increasing prices for consumers.

As part of its commitments, Mehiläinen has promised to cap the prices of these services in clinics in Bucharest, Brașov, and Constanța for a period of three years, except for adjustments related to inflation and justified costs. The company also commits not to condition access to assisted human reproduction services on the purchase of other services and not to offer packages that impose higher prices. The Competition Council invites interested parties to submit comments regarding these commitments until November 27, 2025.